Company intelligence / Profile preview

Seasonale

Montvale, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Seasonale is a well-known brand name for an extended-cycle oral contraceptive, rather than a standalone company. It was developed and brought to market by Barr Pharmaceuticals (specifically through its subsidiary Duramed Pharmaceuticals), which specialized in generic and proprietary women's healthcare products. Seasonale was the first FDA-approved contraceptive designed to reduce the number of menstrual periods to four per year. In 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceutical Industries, which now manages the product portfolio.

Therapeutic areas: Women's Health
Modalities: Small moleculeHormone
Industry: Pharma

Beyond the preview

Go deeper on Seasonale.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seasonale.

Explore the full profile